• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Efficiency of endoscopic treatment with intra gastric balloon in severe to morbid obesity].

作者信息

Houissa Fatma, Trabelsi Senda, Hadj Brahim Kamel, Mouelhi Leila, Bouzaidi Slim, Salem Mohamed, Mekki Haiffa, El Jery Kaouther, Said Yosra, Kheder Sana, Debbech Radhouane, Najjar Taoufik

出版信息

Tunis Med. 2014 Dec;92(12):717-22.

PMID:25879595
Abstract

BACKGROUND

Obesity raises such a healthcare matter throughout the world. Its management is not only complex but also most often multidisciplinary. The medico-dietary treatment is of inconstant efficiency and the surgical treatment, though more efficient, presents a considerable morbidity-death rate. The endoscopic treatment through intra-gastric balloon avails a seducing alternative namely accounting for surgery preparation.

AIM

To assess the efficiency of the endoscopic treatment through gastric balloon, both in the short and long term, and this is accounting for weight loss as well as tolerance.

METHODS

We have carried out a retrospective study including the patients suffering from severe to morbid obesity and who had a gastric balloon implemented in our Endoscopy Unit between November 2005 and December 2007.

RESULTS

Twenty one patients were included. The average age was 32,19 ± 12,65 years with extremes of 16 and 52 years. Fifteen patients suffered from morbid obesity. The patients' average weight was 134, 52 ± 26,46 kg (extremes 88 and 194 kg). Some co-morbidity was found out with 15 patients. Te balloon implementation (Héliosphère®) was carried out with no incidents in all patients. Six months after the balloon implementation, the average weight loss was 17,5% and the average loss of over weigh was 37%. In biological level, we noted a normalisation of fasting glycaemia in 28,6 % of cases, of the cholesterolemia in 100 %, of the triglyceridemia in 33,33%, of the uraemia in 42,8% and hepatic tests in 50 % of the cases. The metabolic syndrome disappeared in 28,57 % of cases. The assessment after a 5-year-period was marked by the need to surgical treatment in 4 patients and this is due to the loss of efficiency of endoscopic treatment. A bad tolerance of gastric balloon was observed in 34 % of the cases, dominated by sicknesses. Only one patient presented incoercible sicknesses with ionic troubles as well as deshydrating requiring the precocious extraction of the balloon after 48 hours of its implementation.

CONCLUSION

The endoscopic treatment through intra gastric balloon is well tolerated but efficiently limited in time. It might be recommended in preparation for a surgical treatment or in case of contre- indication or surgery refusal.

摘要

相似文献

1
[Efficiency of endoscopic treatment with intra gastric balloon in severe to morbid obesity].
Tunis Med. 2014 Dec;92(12):717-22.
2
Dual Intragastric Balloon: Single Ambulatory Center Spanish Experience with 60 Patients in Endoscopic Weight Loss Management.双胃内球囊:一家门诊中心对60例患者进行内镜下减重管理的西班牙经验
Obes Surg. 2015 Dec;25(12):2263-7. doi: 10.1007/s11695-015-1715-6.
3
[Role of intragastric air filled ballon (Heliosphere Bag) in severe obesity. Personal experience].[胃内充气气球(太阳神袋)在重度肥胖症中的作用。个人经验]
Ann Ital Chir. 2009 Mar-Apr;80(2):113-7.
4
The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients.生物肠溶胃内球囊(BIB)治疗肥胖症:亚洲患者效果不佳。
Singapore Med J. 2007 Mar;48(3):227-31.
5
Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficacy.用于“非病态”肥胖的胃内气球:耐受性和疗效的回顾性评估
Obes Surg. 2004 Apr;14(4):539-44. doi: 10.1381/096089204323013587.
6
Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy.胃内气球用于治疗肥胖症:耐受性和疗效的回顾性评估
Obes Surg. 2005 Jan;15(1):101-5. doi: 10.1381/0960892052993558.
7
[Complications in morbid obesity treatment--pylorus obstruction caused by a deflated intragastric balloon].[病态肥胖治疗中的并发症——胃内球囊放气导致幽门梗阻]
Chirurgia (Bucur). 2009 May-Jun;104(3):347-50.
8
BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients.BioEnterics胃内球囊:意大利2515例患者的经验
Obes Surg. 2005 Sep;15(8):1161-4. doi: 10.1381/0960892055002202.
9
Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50).对于超级肥胖患者(体重指数≥50),作为第一阶段手术,腹腔镜袖状胃切除术优于内镜胃内球囊置入术。
Obes Surg. 2005 May;15(5):612-7. doi: 10.1381/0960892053923833.
10
[Intra-gastric ballon in the treatment of morbid obesity].[胃内球囊治疗病态肥胖症]
Acta Med Port. 2011 Jul-Aug;24(4):489-98. Epub 2011 Dec 12.